Faucheux BA - Search Results

1

Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.

Faucheux BA, Martin ME, Beaumont C, Hunot S, Hauw JJ, Agid Y, Hirsch EC. Faucheux BA, et al. J Neurochem. 2002 Oct;83(2):320-30. doi: 10.1046/j.1471-4159.2002.01118.x. J Neurochem. 2002. PMID: 12423242 Free article.

2

Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.

Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC. Faucheux BA, et al. J Neurochem. 2003 Sep;86(5):1142-8. doi: 10.1046/j.1471-4159.2003.01923.x. J Neurochem. 2003. PMID: 12911622 Free article.

3

Metabolic changes in the basal ganglia of patients with Huntington's disease: an in situ hybridization study of cytochrome oxidase subunit I mRNA.

Gourfinkel-An I, Vila M, Faucheux B, Duyckaerts C, Viallet F, Hauw JJ, Brice A, Agid Y, Hirsch EC. Gourfinkel-An I, et al. J Neurochem. 2002 Feb;80(3):466-76. doi: 10.1046/j.0022-3042.2001.00734.x. J Neurochem. 2002. PMID: 11905993 Free article.

4

Neuronal vulnerability in Parkinson's disease.

Hirsch EC, Faucheux B, Damier P, Mouatt-Prigent A, Agid Y. Hirsch EC, et al. J Neural Transm Suppl. 1997;50:79-88. doi: 10.1007/978-3-7091-6842-4_9. J Neural Transm Suppl. 1997. PMID: 9120427 Review.

5

Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease.

Boissière F, Faucheux B, Duyckaerts C, Hauw JJ, Agid Y, Hirsch EC. Boissière F, et al. J Neurochem. 1998 Aug;71(2):767-74. doi: 10.1046/j.1471-4159.1998.71020767.x. J Neurochem. 1998. PMID: 9681468 Free article.

6

trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study.

Benisty S, Boissiere F, Faucheux B, Agid Y, Hirsch EC. Benisty S, et al. Neuroscience. 1998 Oct;86(3):813-26. doi: 10.1016/s0306-4522(98)00126-2. Neuroscience. 1998. PMID: 9692719

7

Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R. Parain K, et al. Neuroreport. 1999 Feb 25;10(3):557-61. doi: 10.1097/00001756-199902250-00021. Neuroreport. 1999. PMID: 10208589

8

Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.

Faucheux BA, Hirsch EC, Villares J, Selimi F, Mouatt-Prigent A, Javoy-Agid F, Hauw JJ, Agid Y. Faucheux BA, et al. J Neurochem. 1993 Jun;60(6):2338-41. doi: 10.1111/j.1471-4159.1993.tb03527.x. J Neurochem. 1993. PMID: 8492137

9

The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.

Faucheux BA, Hauw JJ, Agid Y, Hirsch EC. Faucheux BA, et al. Brain Res. 1997 Feb 21;749(1):170-4. doi: 10.1016/s0006-8993(96)01412-6. Brain Res. 1997. PMID: 9070646

10

Iron metabolism and Parkinson's disease.

Hirsch EC, Faucheux BA. Hirsch EC, et al. Among authors: faucheux ba. Mov Disord. 1998;13 Suppl 1:39-45. Mov Disord. 1998. PMID: 9613717 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters